ICYMI: In anticipation of today’s Cures markup, E&C releases an updated draft while Pew launches a new Rx initiative

May 14, 2015

May 14, 2015 The House Energy and Commerce Committee released an updated Read More

Press Release: New Trend Report Confirms Drug Prices On Unsustainable Path

May 13, 2015

May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half Read More

ICYMI – Where’s Robert Stack When You Need Him?

May 5, 2015

ICYMI May 5, 2015  The New York Times: Runaway Drug Prices How companies set Read More

ICYMI: High Drug Costs Impact Wall Street and Spark a New Initiative in the White House

Apr 28, 2015

April 28, 2015 Note: Distributing the New York Times article below is not an Read More

New Drug Report Confirms Drug Prices On Unsustainable Path

Mar 11, 2015

Reaction from National Coalition on Health Care President and CEO John Rother Read More

Prescription Drug Spending Will Reach $1.3 Trillion – That’s Trillion – By 2018

Nov 20, 2014

It appears that spending on prescription medicines will continue to defy the laws of gravity, according to a new report from IMS Health Institute for Informatics. Read More

[Health Affairs] The $500 Billion Medicare Slowdown: A Story About Part D

Oct 21, 2014

A great deal of analysis has been published on the causes of the health care spending slowdown system-wide — including in the pages of Health Affairs. Read More

[Politico Pro] The new drug war: Health lobbies spar

Oct 15, 2014

Harvoni’s launch brought new howls about price gouging from insurers and a broad coalition of health care groups. They warn that the drugs, no matter how revolutionary, are ultimately unaffordable given the estimated 3 million Americans who may be infected with hepatitis C. Read More

[WSJ] If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Oct 14, 2014

Now that the FDA has approved the Harvoni treatment from Gilead Sciencesand a $94,500 price for a 12-week regimen has been established, attention is turning toward AbbVie and the steps the big drug maker must take to win market share. Read More

[Forbes] ’60 Minutes’ Just Attacked High Drug Prices. Here’s What You Should Know.

Oct 5, 2014

60 Minutes, the most successful news program in American history Read More

[The Wall Street Journal] France Will use Taxes to Pressure Drug Makers on Hep C Prices

Sep 30, 2014

In an effort to blunt the high price of hepatitis C treatments Read More